期刊文献+

替吉奥联合根治性放疗与根治性放疗治疗早期鼻咽癌的比较 被引量:6

Comparison of S-1 Combined with Radical Radiation Therapy and Single Radical Radiation Therapy in Treatment of Early Nasopharyngeal Carcinoma
暂未订购
导出
摘要 目的比较根治性放疗联合替吉奥与单纯根治性放疗治疗早期鼻咽癌的近期疗效和毒性反应.方法2009年1月1日至2010年1月1日,88例早期鼻咽癌患者,随机分为试验组和对照组,每组44例.对照组单一放疗,每周5次,每次2.0 Gy,放疗总剂量为60~66 Gy;试验组于放疗同时口服替吉奥胶囊,替吉奥初始剂量为65 mg/(m2.d),2次/d,周期为第1至第8天,间歇期为2周.结果 88例患者全部完成治疗,均评价为CR,有效率为100%.试验组和对照组2 a局部控制率分别为100%(44/44)和90.9%(40/44),2组相比差异有统计学意义(P<0.05).毒副作用主要为骨髓抑制、胃肠道反应.结论根治性放疗同时联合替吉奥治疗早期鼻咽癌局部控制率优于单纯放疗,远期疗效和毒性反应尚待进一步研究. Objective To explore the curative effect and toxicity of radical radiation therapy combined with S-1 for early nasopharyngeal carcinoma.Methods From Jan.1st 2009 to Jan.1st 2010,88 cases of early early nasopharyngeal carcinoma were divided into two groups: the joint S-1 and radiotherapy group(experimental group) and the single radiotherapy group(control group),and 44 cases in each group.Patients in the control group only received radiation therapy,they were adopted ordinary radiation therapies,five times a week,2.0 Gy each time,total dose was 60 ~ 66 Gy.Patients in the experimental group took S-1 capsules orally while receiving radiation therapy,the initial dose was 65 mg/(m.d),bid,d1~d28 and the intermittent period was twoweeks.Results All of the 88 patients completed treatment,and were evaluated as CR,the effective rate was 100%.2-year local control rates were 100%(44 / 44)for experimental group and 90.9%(40/44)for control group,there was significant difference(P〈0.05)between two groups.The main side effects were myelosuppression and gastrointestinal reactions.Conclusions Radiation therapy combined with S-1 get higher local control ratio than single radiation therapy.But the long-term outcomes and toxicities need to be further investgated.
出处 《昆明医科大学学报》 CAS 2012年第10期93-96,共4页 Journal of Kunming Medical University
关键词 鼻咽癌 替吉奥 根治性放疗 Nasopharyngeal carcinoma S-1 Radical radiation therapy
  • 相关文献

参考文献11

  • 1LEE A W,SZE W M,AU J S,et al. Treatment results fornasopharyngeal carcinoma in the modem era: the HongKong experience [ J ]. Int J Radiat Oncol Biol Phys,2005,61(4):1 107-1 116.
  • 2孙莉.HPLC法测定替吉奥片中3种成分的含量[J].中国药事,2008,22(11):984-986. 被引量:10
  • 3WHO. Handbook for reporting of cancer treatment[M].Geneva (Switzerland ) : World Health Organization OffsetPublication,1979 : 48.
  • 4BROCKSTEIN B E. Management of recurrent head and n-eck cancer: recent progress and future directions [J].Drugs,2011,71(12):1 551-1 559.
  • 5SAIF M W,ROSEN L S,SAITO K,et al. A phase I studyevaluating the effect of CDHP as a component of S-l on thepharmacokinetics of 5-fluorouracil [J]. Anticancer Res,2011,31(2):625-632.
  • 6OHNISHI K , SHIOYAMA Y,NAKAMURA K , et al. Co-ncurrent chemoradiotherapy with S-l as first-line treatmentfor patients with oropharyngeal cancer [J]. J Radiat Res^2011,52(1):47-53.
  • 7MORIMOTO M,TAKEMURA H,YUI T,et al. Efficacy ofconcomitant therapy with S-l,CDGP,and radiation forlaryngeal cancer [J]. Gan To Kagaku Ryoho,2010,37(10):1903-1 906.
  • 8OHASHI T,OHNISHI M,TANAHASHI S,et al. Ecacyand toxicity of concurrent chemoradiotherapy withnedaplatin and S-l for head and neck cancer [J]. Jpn JClin Oncol,2011,41(3):348-352.
  • 9BEDWINEK J M,PEREZ C A,KEYS D J. Analysis of fa-ilures after definitive irradiation for epidermoid carcinoma ofthe nasopharynx[j]. Cancer, 1980,45(4) :2 725—2 729.
  • 10SANGUINETI G,GEARA F,GARDEN A,et al. Carcino-ma of the nasopharynx treated by radiotherapy alone:determinants of local and regional control[j]. Int J RadiatOncol Biol Phys ,1997,37(7): 985-996.

二级参考文献7

  • 1张晗.治疗胃癌的复方新药S-1的研究进展[J].国外医学(药学分册),2005,32(5):304-307. 被引量:8
  • 2戚苏明,刘江华,曹燕锋,蔡伟,顾志兰.替吉奥胶囊处方优选[J].中国药业,2006,15(11):44-45. 被引量:3
  • 3Sato A, Ito T, Tomita T, et al. Chemotherapy of gastric cancer-a review of clinical trials in Japan [J]. Gan To Kagaku Ryoho, 2002, 29 (9): 1522.
  • 4Tanaka F, Fukuse T, Wada H, et al. The history, mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agents [J]. Curt Pharm Biotechnol, 2000, 1 (2): 137.
  • 5Terashima M, Fujiwara H, Takagane A, et al. Prediction of sensitivity of fluoropyrimidines by metabolic and target enzyme activities in gastric cancer [J]. Gastric Cancer, 2003, 6 (Suppl 1): 71.
  • 6Yoshisue K, Hironaga K, Yamaguchi S, et al. Reduction of 5- fluorouracil gastroiontestinal toxicity resulting from the prtection of thymidylate synthase in gastrointestinal tissue by repeated simultaneous administration of potassium oxonate in rats [J]. Cancer ChemotherPharmacol, 2000, 46 (1): 51.
  • 7Yoshisue K, Masuda H, Matsushima E, et al. Tissue distribution and biotransformation of potassium oxonate after oral administration of a novel antitumor agent(drug combination of tegafur, 5- chloro-2,4-dihydroxypyridine, and potassium oxonate) to rats[J]. Drug Metab Dispos, 2000,28 (10) : 1162.

共引文献9

同被引文献40

  • 1管忠震,徐瑞华.奈达铂临床研究进展[J].中国肿瘤临床,2004,31(13):774-780. 被引量:176
  • 2易俊林,高黎,黄晓东,李素艳,罗京伟,徐国镇.鼻咽癌放射治疗的失败模式[J].中华放射肿瘤学杂志,2004,13(3):145-148. 被引量:89
  • 3CaballeroGA,AusmanRK,QuebbemanEJ.Long-term,ambulatory,continuous IV infusion of 5-FU for the treatment of advanced adenocarcinomas.Cancer Treat Rep,1985;69:13-15.
  • 4Lokich JJ,Ahlgren JD,GulIo J J, et al.A prospective randomized comparisonof continuous infusion fluoroaracil with a conventional bolus schedule in metastatic eolonrectal eareinoma:a Mid-Atlantic Oneology Prograrn Study.J Clin Oncol, 1989;7:425-432.
  • 5Tsukuda M,Ogasawara H,Kaneke S,Cooper K, el al. A prospective randomized trial of adjuvant chemotherapy with LIFT for head and neck carcinoma.Head and Neck UFT Sludy Group.Gan To Kagaku Ryoho, 1994;21 : 1169-1177.
  • 6Moynihan T, Hansen R,Anderson T, et aI.Continuous 5-fluorouracil infusion in advanced gastric carcinoma.Am J Clin Oncol, 1988;11:461-464.
  • 7Tsushima T, Hironaka S,Boku N,et ah Safety and efficacy of S-I monotherapy in elderly patients with advanced gastric cancer[J].Gastric Cancer,2010; 13:245-250.
  • 8Emi M,Yamaguchi Y, Hihara J,et al. Phase I trial of oxaliplatin plus S-I chemotherapy in patients with metastatic colorectal cancer[J].Oncol Lett,2010;1:95-98.
  • 9Aupiirin A,Lep l,Choux C,et al.Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer[J].J Clin Oneol,2010;28 (13) :2181 -2190.
  • 10Ohashit,Ohnishim, Tanahastt S,et al.Efficaeyand toxicity of concurrent chemoradiotherapy with nedaplatin and S-I for head and neck cancer[J].Jpn J Clin Oncol,2011 ;41 (3):348-352.

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部